{"schema":"hottub-news/story/v1","story":"st_njkxt6ocy2zkr6rusu5a","title":"Roche-Tochter Chugai beendet die Entwicklung von Emugrobart bei Übergewicht","title_en":"Roche subsidiary Chugai ends development of Emugrobart for obesity","outlets":2,"brief":null,"page":"https://hottub.news/stories/roche-subsidiary-chugai-ends-development-of-emugrobart-for-obesity-njkxt6ocy2","count":2,"items":[{"id":"n_3vwh4rngcjojgrpqlwga","seq":408109,"kind":"article","title":"Chugai beendet Entwicklung von Emugrobart bei Übergewicht","title_en":"Chugai ends development of Emugrobart for obesity","url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2026/09/28/chugai-beendet-entwicklung-von-emugrobart-bei-uebergewicht","summary":"Der Myostatin-Antikörper Emugrobart wird nicht länger für den Einsatz bei Adipositas untersucht. Wiederaufgenommen werden soll die Forschung unterdessen in der Indikation spinale Muskelatrophie.","published":"2026-09-28T10:30:00Z","seen":"2026-09-28T11:11:10Z","lang":"de","country":"DE","source":{"id":"kite-purplemanager-com-0a68d5","name":"purplemanager.com","domain":"feeds.purplemanager.com"},"via":"kite-purplemanager-com-0a68d5","topics":["healthcare","germany","pharma-und-partner","wirtschaft"],"authors":["dpa"],"story":"st_njkxt6ocy2zkr6rusu5a","category":"health","category_p":0.4300000071525574,"category2":"economy-business","sentiment":"positive","tone":-0.03999999910593033,"political":0.05000000074505806},{"id":"n_njkxt6ocy2zkr6rusu5a","seq":379503,"kind":"article","title":"Roche-Tochter Chugai beendet die Entwicklung von Emugrobart bei Übergewicht","title_en":"Roche subsidiary Chugai ends development of Emugrobart for obesity","url":"https://www.cash.ch/news/top-news/roche-tochter-chugai-beendet-die-entwicklung-von-emugrobart-bei-ubergewicht-972045","summary":"Pharma - Die japanische Roche-Tochter Chugai stellt die klinische Entwicklung von Emugrobart ein.","published":"2026-09-28T07:44:14Z","seen":"2026-09-28T08:44:27Z","lang":"de","country":"CH","source":{"id":"kite-cash-ch-42f33f","name":"cash.ch","domain":"cash.ch","outlet":{"wikidata":"Q1047289","name":"Cash","type":"newspaper","country":"CH","designations":["business newspaper","online newspaper"]}},"via":"kite-cash-ch-42f33f","topics":["news"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"}],"image":"https://www.cash.ch/fp/1200/675/1063/698/sites/default/files/media/field_image/2025-10/roche_analyse_biotech.jpeg","story":"st_njkxt6ocy2zkr6rusu5a","category":"health","category_p":0.5400000214576721,"category2":"economy-business","sentiment":"negative","tone":-0.09000000357627869,"political":0.05000000074505806}]}